Management Buyout Valuation UK: Pricing, Funding and Tax

What an MBO valuation actually has to do

A management buyout is the only transaction where the buyer already knows everything the seller knows. The management team has run the business, built the forecast and seen the pipeline. That asymmetry is not in the vendor's favour, and it is the reason an MBO price is scrutinised more heavily than an equivalent trade sale.

An MBO valuation therefore has three audiences at once, and it fails if it only satisfies one:

• The vendors, who need evidence that the price they are accepting from their own managers reflects fair value rather than a negotiated convenience.
• The funders, who will lend against cash flow and want to see the valuation reconciled to a debt capacity model.
• The management team, who need a number they can defend to a lender, an investor and, later, to HMRC if any part of their equity is acquired at a value below market.

The output is not a single figure. It is a defensible range, a stated basis of value, and an explicit statement of the deal structure assumed.

The starting point: sustainable earnings, not last year's profit

MBO pricing in the UK SME market is almost always built on a multiple of normalised EBITDA. The normalisation work matters more in an MBO than in a trade sale, because several of the adjustments cut in the buyer's favour rather than the seller's.

Adjustments that usually increase EBITDA:

• Owner-director remuneration and dividends rebased to a market salary for the role the outgoing owner actually performed.
• Rent paid to a connected party above market rate, or management charges to a holding company that will not continue.
• Genuinely non-recurring items - a one-off legal dispute, a restructuring, an abnormal bad debt.

Adjustments that usually reduce EBITDA in an MBO specifically:

• The cost of replacing the departing owner. If the vendor was also the principal salesperson, technical lead or key relationship holder, the buyout entity has to hire that capability. This is the single most commonly understated adjustment in management-led deals.
• Costs previously absorbed by the vendor's wider group - insurance, IT, finance function, guarantees.
• Incremental cost of the post-transaction capital structure: audit, covenant reporting, non-executive chair, monitoring fees.

A credible MBO EBITDA bridge shows both directions. A bridge that only adds back is a negotiating document, not a valuation.

Choosing the multiple

The multiple applied in an MBO is generally at or slightly below the range a strategic trade buyer would pay for the same business, for two structural reasons: there are no synergies to share, and the buyer is funded by leverage rather than a corporate balance sheet.

In practice the multiple and the structure are negotiated together. A vendor pushing for a full multiple usually ends up accepting more deferred consideration; a vendor who wants cash at completion is normally accepting a lower headline.

From enterprise value to what the vendor actually receives

The equity bridge is identical in mechanics to a trade sale, but the MBO context adds a step: the price has to survive the funding structure.

Enterprise value = normalised EBITDA x multiple

Equity value = enterprise value - net debt +/- working capital adjustment + surplus assets

Then, uniquely in an MBO:

Funded consideration at completion = senior debt drawn + management equity + investor equity, with the balance of the equity value paid through deferred consideration, vendor loan notes or an earn-out.

A worked illustration on a professional services business:

The gap at the bottom of that table is where most MBOs are won or lost. If the vendor will not accept deferred consideration, the deal has to be repriced or refunded, not simply renegotiated at the margin.

Debt capacity: the constraint that sets the ceiling

UK lenders to the lower mid-market will typically support senior leverage of around 2 to 3 times normalised EBITDA for a stable, cash-generative business, with cash-flow cover tested against interest and amortisation. Asset-backed businesses can go further through invoice finance or asset-based lending; asset-light businesses with concentrated revenue will go less far.

Because of this, an MBO valuation that ignores funding is of limited use. Two businesses with the same EBITDA and the same defensible multiple can support very different completion payments if one converts 95% of EBITDA to cash and the other funds a growing debtor book. Modelling debt capacity alongside the valuation is what prevents a deal agreeing a price in month two that collapses in month six.

The tax point management teams underestimate

Where the management team acquires shares as part of their employment - and in almost every MBO they do - the shares are employment-related securities under Part 7 of ITEPA 2003. If they acquire those shares for less than unrestricted market value, the difference is taxed as employment income.

Three consequences follow:

1. The share price paid by management must be supportable by valuation evidence, not simply set at par or at a convenient round number.

2. Where the shares carry restrictions - leaver provisions, transfer restrictions, compulsory transfer on termination - a section 431 election made within 14 days of acquisition is normally advisable, so that future growth is taxed as capital rather than income.

3. If the structure uses growth shares or sweet equity so that management participate only above a hurdle, the hurdle has to be set by reference to a proper valuation of the company at the date of issue. Set it too low and there is an immediate income tax charge; set it too high and management have no realistic incentive.

Vendors have their own tax position to coordinate - notably Business Asset Disposal Relief eligibility and the treatment of any share-for-share exchange or loan note consideration. These are matters for the company's tax adviser, but the valuation has to be in place before those decisions can be made properly.

Where valuations go wrong in MBOs

• Management's own forecast used unadjusted. The buyer wrote the plan. A valuation that simply discounts management's numbers has no independence.
• No adjustment for the vendor's role. The most expensive omission in the sector.
• Synergies left in. Benefits arising from the vendor's other interests, group buying power or shared overhead disappear at completion.
• Ignoring the minority position. Where management acquires less than 100%, or where a co-investor takes a stake, control and marketability adjustments apply to the relevant parcels of shares - they are not simply pro-rata slices of equity value.
• A single point estimate. MBOs are negotiated over months. A range with stated sensitivities survives that process; a single number does not.

Practical sequence for a UK MBO

1. Establish an independent value early, before any price is discussed between vendor and management. It is far harder to move a number that has already been said out loud.

2. Build the normalised EBITDA bridge with evidence - payroll records, lease comparables, invoices for one-off items.

3. Test the debt capacity against the valuation so the achievable completion payment is known before funders are approached.

4. Fix the equity structure - ordinary shares, growth shares or options - and value the management instruments at that point.

5. Make the section 431 elections within 14 days of any acquisition of restricted securities.

6. Keep the valuation current. If the transaction runs past two quarters, the earnings base has moved and the report should be refreshed.

How Optival supports MBO valuations

We prepare independent valuations for UK SME management buyouts: a defensible value range with a documented EBITDA bridge, comparables evidence, a debt capacity sensitivity where required, and a summary letter suitable for lenders and incoming investors. Where the deal involves management sweet equity or growth shares, we value those instruments on the same evidence base so the tax position holds together.

MBO valuations are delivered under our Business Sales offer, and management equity instruments under Growth Share Valuation. If you want to see the scope in detail, the MBO valuation page sets out deliverables and timescales.

Related reading: How buyers value UK SMEs, EBITDA adjustments and normalised accounts, net debt and the cash-free debt-free bridge, and the section 431 election.